Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

IMW 2019 | An update on the genomic landscape of MM

Brian Walker • 15 Sep 2019
IMW 2019
Multiple Myeloma

Brian Walker, PhD, the University of Arkansas for Medical Sciences, Little Rock, AR, discusses the important aspects of myeloma genomics and how exome sequencing in large patient cohorts has revealed the prognostic significance of biallelic inactivation of TP53 and other mutations. This interview was held at the International Myeloma Workshop (IMW) 2019, held in Boston, MA.

More from Brian Walker

The future of myeloma therapy
Brian Walker et al. • 15 Apr 2023
0:55
Important genomic factors for SM progression
Brian Walker • 13 Sep 2019
0:42
Non-coding mutations impact gene expression in myeloma
Brian Walker • 13 Sep 2019
12:00
Re-evaluating the role of epigenetics in multiple myeloma
Brian Walker et al. • 18 Oct 2017

Related Videos

0:59
Looking forward to COMy 2024: celebrating 10 years
Mohamad Mohty • 17 Apr 2024
0:57
Overcoming barriers to treating older patients with myeloma
Sergio Giralt • 16 Apr 2024
1:01
The potentially curative role of CAR-T therapy in myeloma
Sergio Giralt • 16 Apr 2024
1:45
Expanded approval of cilta-cel in myeloma: the value of bringing CAR-T cells into earlier lines
Monika Engelhardt • 16 Apr 2024
The content of VJHemOnc is intended for healthcare professionals